연구성과로 돌아가기
2023 연구성과별 연구자 정보 (37 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Lee, Jeong-Ok | Lee, JO | 10 | Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Seongnam, South Korea | J-5603-2012 | Lee, Jong-Seok | kstwoh@skku.edu;drydh1685@hotmail.com; | |||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Jo, Jae-Cheol | Jo, JC | 11 | Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea | CAE-9453-2022 | Jo, Jae-Cheol | kstwoh@skku.edu;drydh1685@hotmail.com; | |||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Yang, Deok-Hwan | Yang, DH | 12 | 교신저자 | Chonnam Natl Univ, Med Sch, Hwasun, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | ||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Yang, Deok-Hwan | Yang, DH | 12 | 교신저자 | Hwasun Hosp, Hwasun, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | ||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Yang, Deok-Hwan | Yang, DH | 12 | 교신저자 | Chonnam Natl Univ, Dept Hematol Oncol, Med Sch, 322 Seoyang Ro, Hwasun 58128, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | ||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Yang, Deok-Hwan | Yang, DH | 12 | 교신저자 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | ||||
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Choi, Seung Won | Choi, SW | 1 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea | nsnam@ssku.edu;sehoon.lee@samsung.com; | |||||
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Jung, Hyun Ae | Jung, HA | 2 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea | nsnam@ssku.edu;sehoon.lee@samsung.com; | |||||
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Cho, Hee-Jin | Cho, HJ | 3 | Kyungpook Natl Univ, Dept Biomed Convergence Sci & Technol, Daegu, South Korea | nsnam@ssku.edu;sehoon.lee@samsung.com; | |||||
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Kim, Tae Min | Kim, TM | 4 | Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst,Dept Internal Med, Seoul, South Korea | B-9921-2013 | Kim, Tae | 0000-0001-6145-4426 | Kim, Tae Min | nsnam@ssku.edu;sehoon.lee@samsung.com; | |
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Park, Chul-Kee | Park, CK | 5 | Seoul Natl Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea | J-5499-2012 | Park, Chul-Kee | 0000-0002-2350-9876 | Park, Chul-Kee | nsnam@ssku.edu;sehoon.lee@samsung.com; | |
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Nam, Do-Hyun | Nam, D | 6 | 교신저자 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea | nsnam@ssku.edu;sehoon.lee@samsung.com; | ||||
| A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification | Lee, Se-Hoon | Lee, SH | 7 | 교신저자 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea | nsnam@ssku.edu;sehoon.lee@samsung.com; | ||||
| A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye | Eom, Youngsub | Eom, Y | 1 | Korea Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea | 0000-0001-9475-4409 | Eom, Youngsub | hyomkim@kumc.or.kr; | |||
| A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye | Eom, Youngsub | Eom, Y | 1 | Korea Univ, Ansan Hosp, Dept Ophthalmol, Seoul, Gyeonggido, South Korea | 0000-0001-9475-4409 | Eom, Youngsub | hyomkim@kumc.or.kr; |
페이지 이동: